Funding the Development of a Mouse Model for the Research on Friedreich’s Ataxia

We are currently considering a new form of funding for Professor Tremblay’s project. Our goal is to develop a mouse model for the research on Friedreich’s Ataxia. The research project will soon be published in the American crowdfundig site CONSANO. Ataxia Canada will contribute equally to the amount collected. Access to...

Continue reading

AmorChem, Université Laval and CHU de Québec collaborate on the development of a treatment for Friedreich’s Ataxia

NEWS RELEASE AmorChem, Université Laval and CHU de Québec collaborate on the development of a treatment for Friedreich’s Ataxia Montreal, August 4, 2014 – AmorChem, Université Laval and the CHU de Québec are happy to announce the start of a collaboration focusing on the discovery of a new treatment to...

Continue reading

Health Canada Approves Catena® for Treatment of Friedreich’s Ataxia

News Release Liestal, Switzerland, July 24, 2008 – Santhera Pharmaceuticals (SWX:SANN), a Swiss specialty pharmaceutical company focused on neuromuscular diseases, announced today that Health Canada has approved with conditions SNT-MC17/idebenone for the treatment of Friedreich’s Ataxia. Health Canada’s decision is the first marketing authorization worldwide for any Friedreich’s Ataxia therapy....

Continue reading